在儿科耐药性中神经调节
Ann Hyslop1, Marytery Fajardo2
1Department of Neurology and Neurological Sciences, Stanford University School of Medicine, 750 Welch Rd, Palo Alto, CA 94304, United States.
Epilepsy & behavior : E&B
|February 27, 2025
概括
本综述涵盖了针对儿童耐药性的三种神经调节装置:迷走神经刺激,响应性神经刺激和深度大脑刺激. 它详细介绍了它们的机制,试验,有效性和不良影响.
科学领域:
- 神经学 神经学
- 生物医学工程 生物医学工程
- 儿科症 儿科症
背景情况:
- 耐火性影响了许多儿童,通常仅用药物治疗是不够的.
- 神经调节为难以治疗的病例提供了替代治疗策略.
- 有几种神经调节装置在商业上可用,在儿科患者中越来越多地应用.
研究的目的:
- 为提供三种FDA批准的耐火性神经调节器件的高级概述.
- 突出这些设备在儿科患者中的应用和考虑.
- 总结可用的神经调节疗法的机制,临床证据和安全性概况.
主要方法:
- 关键临床试验和监管机构提交的关于迷走神经刺激,响应性神经刺激和深度大脑刺激的审查.
- 综合了关于器械机制,疗效结果和不良事件概况的数据.
- 专注于涉及患有耐火性的儿科群体的研究.
主要成果:
- 迷你神经刺激,响应性神经刺激和深度大脑刺激在儿童中显示出不同程度的发作减少.
- 每种模式都有不同的作用机制和植入程序.
- 常见的不良反应通常是可以管理的,尽管每个设备都有特定的风险.
结论:
- 神经调节在治疗儿童耐火性方面取得了重大进展.
- 设备的选择取决于个体患者的因素,的特征和医生的专业知识.
- 持续的研究对于优化神经调节策略和扩大其在儿科中的应用至关重要.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
209
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
209
Antiepileptic Drugs: Glutamate Antagonists
267
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
267
Antiepileptic Drugs: Potassium Channel Activators
140
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
140
Antiepileptic Drugs: GABAergic Pathway Potentiators
306
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
306
Antiepileptic Drugs: Sodium Channel Blockers
340
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
340
Antiepileptic Drugs: Calcium Channel Blockers
290
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
290


